1. Home
  2. MDAI vs EKSO Comparison

MDAI vs EKSO Comparison

Compare MDAI & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAI
  • EKSO
  • Stock Information
  • Founded
  • MDAI 2013
  • EKSO 2005
  • Country
  • MDAI United States
  • EKSO United States
  • Employees
  • MDAI N/A
  • EKSO N/A
  • Industry
  • MDAI Medical/Dental Instruments
  • EKSO Medical/Dental Instruments
  • Sector
  • MDAI Health Care
  • EKSO Health Care
  • Exchange
  • MDAI Nasdaq
  • EKSO Nasdaq
  • Market Cap
  • MDAI 23.8M
  • EKSO 19.1M
  • IPO Year
  • MDAI N/A
  • EKSO N/A
  • Fundamental
  • Price
  • MDAI $1.14
  • EKSO $0.70
  • Analyst Decision
  • MDAI Strong Buy
  • EKSO Strong Buy
  • Analyst Count
  • MDAI 3
  • EKSO 2
  • Target Price
  • MDAI $4.50
  • EKSO $5.50
  • AVG Volume (30 Days)
  • MDAI 587.1K
  • EKSO 114.4K
  • Earning Date
  • MDAI 11-06-2024
  • EKSO 10-28-2024
  • Dividend Yield
  • MDAI N/A
  • EKSO N/A
  • EPS Growth
  • MDAI N/A
  • EKSO N/A
  • EPS
  • MDAI N/A
  • EKSO N/A
  • Revenue
  • MDAI $27,264,000.00
  • EKSO $17,682,000.00
  • Revenue This Year
  • MDAI $59.53
  • EKSO $1.11
  • Revenue Next Year
  • MDAI N/A
  • EKSO $38.63
  • P/E Ratio
  • MDAI N/A
  • EKSO N/A
  • Revenue Growth
  • MDAI 44.52
  • EKSO 4.12
  • 52 Week Low
  • MDAI $0.82
  • EKSO $0.70
  • 52 Week High
  • MDAI $3.72
  • EKSO $3.13
  • Technical
  • Relative Strength Index (RSI)
  • MDAI 40.97
  • EKSO 27.73
  • Support Level
  • MDAI $1.35
  • EKSO $0.70
  • Resistance Level
  • MDAI $1.58
  • EKSO $0.81
  • Average True Range (ATR)
  • MDAI 0.18
  • EKSO 0.06
  • MACD
  • MDAI -0.04
  • EKSO -0.01
  • Stochastic Oscillator
  • MDAI 22.03
  • EKSO 7.50

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Share on Social Networks: